Browsing by Author "Shitara, Kohei"
Now showing items 1-4 of 4
-
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
Fucà, Giovanni; Cohen, Romain; Lonardi, Sara; Shitara, Kohei; Elez Fernandez, Mª Elena; Fakih, Marwan; Diez Garcia, Marc (BMJ, 2022-02) -
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS
Tabernero Caturla, Josep; Alsina Maqueda, Maria; Shitara, Kohei; Doi, Toshihiko; Dvorkin, Mikhail; Mansoor, Wasat (Springer, 2020-07) -
Quality of life with first-line pembrolizumab for PD-L1–positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study
Van Cutsem, Eric; Valderrama, A.; Bang, Yung-Jue; Fuchs, Charles; Shitara, Kohei; Janjigian, Yelena Yuriy; Alsina Maqueda, Maria (Elsevier, 2021-08) -
Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study
Tabernero Caturla, Josep; Shitara, Kohei; Zaanan, Aziz; Doi, Toshihiko; Lorenzen, S.; Van Cutsem, Eric; Alsina Maqueda, Maria (Elsevier, 2021-08)